FAPM is a synthetic β-methoxyacrylates compound, which has been identified as a potent inhibitor of STAT3 activation and exhibits salutary effects when used in the treatment of myeloid leukemia [13,14]. The gene discussed is STAT3; the disease is myeloid leukemia.